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Abstract
Background: Jiao-Tai-Wan (JTW), composed of Rhizome Coptidis and Cortex Cinnamomi, is a classical traditional
Chinese prescription for treating insomnia. Several in vivo studies have concluded that JTW could exert its
therapeutical effect in insomnia rats. However, the specific mechanism is still unclear. The present study aimed
to explore the effect of JTW on sleep in obesity-resistant (OR) rats with chronic partial sleep deprivation (PSD)
and to clarify its possible mechanism.
Methods: JTW was prepared and the main components contained in the granules were identified by 3D-High
Performance Liquid Chromatography (3D-HPLC) assay. The Male Sprague-Dawley (SD) rats underwent 4 h PSD by
environmental noise and the treatment with low and high doses of JTW orally for 4 weeks, respectively. Then sleep
structure was analyzed by electroencephalographic (EEG). Inflammation markers including high-sensitivity C reactive
protein (hs-CRP), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) levels were examined in the rat plasma.
Meanwhile, metabolic parameters as body weight increase rate, fasting plasma glucose (FPG), fasting insulin (FINS)
levels and insulin resistance index (HOMA-IR) were measured. The expressions of clock gene cryptochromes (Cry1
and Cry2) and inflammation gene nuclear factor-κB (NF-κB) in peripheral blood monocyte cells (PBMC) were also
determined.
Results: The result showed that the administration of JTW significantly increased total sleep time and total slow
wave sleep (SWS) time in OR rats with PSD. Furthermore, the treatment with JTW reversed the increase in the
markers of systemic inflammation and insulin resistance caused by sleep loss. These changes were also associated
with the up-regulation of Cry1 mRNA and Cry 2 mRNA and the down-regulation of NF-κB mRNA expression in
PBMC.
Conclusions: This study suggests that JTW has the beneficial effects of improving sleep, inflammation and insulin
sensitivity. The mechanism appears to be related to the modulation of circadian clock and inflammation genes
expressions in PBMC.
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Background
Sleep loss has become a global problem due to social-
economic factors in the modern society. Since sleep is
important to recover our energy, inadequate sleep is al-
ways thought to be a reason for weight loss [1]. How-
ever, growing evidence suggests that sleep curtailment is
a new risk factor for the development of obesity and
type 2 diabetes [2, 3]. For instance, in the United States,
self-reported sleep duration has decreased by 1.5 ~ 2 h
in the last 50 years coinciding with an increase in obesity
and diabetes [4]. In China, nearly one-third of the popu-
lation reported poor sleep quality or shortened sleep
duration (≤6 h). Compared to subjects with good quality
sleep who slept for 6-8 h per night, those who have poor
sleep quality and short sleep duration were more likely
to have diabetes [5].
With regard to the pathophysiology of sleep loss-
associated obesity and diabetes, present literature high-
lights the role of inflammation and insulin resistance
(IR) after sleep curtailment [6]. Clinical studies have
found that plasma inflammatory cytokines increase sig-
nificantly with the activation of cellular inflammation
[7]. These alterations could be observed even after one
night of sleep deprivation [8]. The existence of chronic
low-grade inflammation may be associated with IR and
precedes the onset of type 2 diabetes in adults [9]. Thus
getting enough good sleep plays an important role of
maintaining metabolic health. In addition, insomnic
patients often take sedative-hypnotics, antipsychotics,
antidepressants and anti-anxiety medications. Abnor-
mal long sleep duration and increased appetite associ-
ated with these drugs may also cause insulin
resistance and high risk of weight-gain. Therefore, the
therapy with a dual-effect of sleep and IR improve-
ment is promising [10].
Jiao-Tai-Wan (JTW), composed of Rhizome Coptidis
(Coptis chinensis Franch, Ranunculaceae) and Cortex
Cinnamomi (Cinnamomum cassiaPresl, Lauraceae), is a
classical traditional Chinese prescription for treating in-
somnia [11]. The application of JTW to treat insomnia
can be traced back to Han Shi Yi Tong in Ming Dynasty.
The function of Rhizome Coptidis (Huanglian in Chin-
ese) is to clear away heart fire and the function of Cortex
Cinnamomi (Rougui in Chinese) is to warm kidney
water. According to a survey, Rhizome Coptidis was one
of the top 10 individual Chinese herbs prescribed for in-
somnia in Taiwan during 2002 [12]. In a meta-analysis
within 217 reviewed studies, JTW was one of the 10
most frequently examined standardized Chinese herbal
formulas for insomnia [13]. In in vivo studies, JTW has
been proven to play its sedative and hypnotic role on in-
somnia rats [14, 15]. Previous researches have demon-
strated that JTW also exhibits hypoglycemic effect and
insulin sensitizing activity in diabetic rodents and
diabetic patients [16, 17]. The possible mechanisms may
be related to suppressing gluconeogenesis by activating
adenosine 5′-monophosphate-activated protein kinase in
the liver and enhancing insulin signaling through phos-
phatidylinositol 3-kinase pathway in the skeletal muscle
[18, 19]. Given that sleep loss induces inflammation and
IR, we hypothesize that JTW may have the potential to
alleviate inflammation and improve insulin sensitivity
after sleep curtailment. Also, one study suggested that
multiple-dose oral administration of JTW may improve
its absorption in insomnic rats compared with normal
rats, which will increase the bioavailability, and give full
play of its therapeutical effect [20]. Therefore, we estab-
lished a rat model of chronic partial sleep deprivation
(PSD) and investigated the effects and mechanisms of
JTW on sleep structure, inflammation and IR.
Methods
Animals
Male Sprague-Dawley (SD) rats (n = 250, 10 weeks, 200
± 20 g) were supplied by Hubei Province Center for Dis-
ease Control and Prevention (Wuhan, China). The rats
were maintained on 12 h light-12 h dark cycle in a hu-
midity- and temperature-controlled environment. All
procedures were approved by Huazhong University of
Science and Technology Ethics Committee for the use
of experimental animals (IRB ID: TJ-A20131218). After
fed with food and water ad libitum for 1 week, all rats
were switched to a high-fat, high-energy diet (8% corn
oil, 44% sweetened condensed milk, 48% standard rat
chow) for 2 weeks. Then 100 rats with the lowest weight
gain (about 40%) were classified as obesity-resistant
(OR) rats [21]. As has been previously proved, better
sleep quality may confer obesity protection in OR rats
[22]. However, chronic partial sleep deprivation increases
body weight even in OR rats which is mostly consistent
with human conditions [23]. Accordingly, OR rat is an
excellent animal model to study sleep loss-associated
obesity and IR [24].
Preparation of JTW
JTW is composed of Rhizome Coptidis and Cortex
Cinnamomi. The ratio of these two herbs is 10:1 (w/w).
In the present study, we use Rhizome Coptidis and
Cortex Cinnamomi concentrated granules (purchased
from China Resources Sanjiu Medical and Pharmaceut-
ical Co., Ltd) for rat administration. Rhizome Coptidis
and Cortex Cinnamomi were all purchased from Rui
Sheng Yuan Biotechnology Co., Ltd. (Chengdu, China)
and identified by Department of Chinese Medicine
Authentication of Jin Chan Pharmaceutical Co., Ltd.
(Hefei, China). All the samples are deposited in the
herbarium of the same department with voucher num-
ber No. 472 for Rhizoma Coptidis, No. 353 for Cortex
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Cinnamomi. The herbs were extracted by using a
method of simulated family decoction with boiling
water. Then the extracts were concentrated, isolated,
dried to form granules. This process of production was
performed according to Good Manufacturing Practice
(GMP) for Drugs (Chinese FDA, 2010 Version) to
ensure the quality control. And the obtained products
were re-identified by Guangdong Institute for Food and
Drug Control (Guangzhou, China). As a result, 0.5 g of
Rhizome Coptidis granule efficacy is equivalent to 3 g
decoction pieces and 1 g of Cortex Cinnamomi granule
efficacy is equivalent to 3 g decoction pieces. We mixed
the granules together by distilled warm water and
administered to the rat at the decoction (not granule)
pieces dosage of 1.1 g/kg and 2.2 g/kg body weight/day,
respectively. The calculation method was as follows: for
a person with body weight of 60 kg, the high dose of
daily JTW intake is 22 g (20 g of Rhizoma Coptidis and
2 g of Cortex Cinnamomi). According to the conversion
of human doses (Chinese Pharmacoepia, 2010) to rat
equivalent doses based on body surface areas, the daily
dose of JTW intake in rats is 6 times higher than human.
Therefore, we chose 2.2 g/kg body weight as the daily
dose by gavage to the rat.
Determination of the main chemical constituents in JTW
by 3D-HPLC analysis
The main chemical constituents in JTW were identified
by 3D-High Performance Liquid Chromatography (3D-
HPLC) method (Fig. 1a). The reference standards of cin-
namaldehyde, cinnamon acid, palmatine chloride and
berberine hydrochloride were purchased from National
Institutes for Food and Drug Control (Beijing, China).
The reference standards of coptisine hydrochloride and
jatrorrhizine hydrochloride were purchased from Tauto
Biotechnology Ltd. (Shanghai, China) (Fig. 1b). For the
analysis, the drying powder Rhizome Coptidis (0.25 g)
and Cortex Cinnamomi (0.05 g) were accurately
weighed, mixed and extracted with 100 ml of methanol
in an ultrasonic bath for 60 min. Additional methanol
was added to compensate for any lost volume. Then the
resulting solution was filtered through a 0.45 μm mem-
brane filter prior to HPLC injection. HPLC was per-
formed on a Waters 2695-2996HPLC system (Waters
Corporation, Milford, MA, USA) equipped with an
Agilent TC-C18 column (4.6 mm× 250 mm, 5um). The
mobile phase included acetonitrile (A) and 0.05 mol/l po-
tassium dihydrogen phosphate (B) at a flow speed of
1.0 ml/min in the condition of column temperature 30 °C.
The detection wavelength was set at 270 nm and the sam-
ple injection volume was 10 μl. The gradient elution was
as follows: 0 ~ 5 min, 85% ~ 85% B, 5 ~ 40 min, 85% ~ 57%
B. Chromatographic data was collected and analyzed by
using Waters Empower 3 software. Moreover, ten batches
of JTW which were supplied by China Resources Sanjiu
Medical and Pharmaceutical Co., Ltd. were used to detect
the similarity (Fig. 1c). The similarity of fingerprints was
analyzed by professional software named Similarity
Evaluation System for Chromatogram Fingerprint of
Traditional Chinese Medicine (version of 2004A).
Experimental design
Selected OR rats were switched to standard laboratory
chow and randomly allocated to four groups, control
group, model group, low dose JTW treated group
(JTW1) and high dose JTW treated group (JTW2) (25
rats in each group). Rats in model group and JTW
treated group were subjected to PSD during the light
phase (4 h/day from 10:00 to 14:00) for 4 weeks. Sleep
deprivation was achieved by exposing the animals to
environmental noise, as previously described [23]. Mean-
while, rats in JTW1 and JTW2 treated group were
respectively given low and high doses of JTW granules
by intragastric administration once a day. Five rats in
each group were sacrificed to collect blood samples at
the 1st, 2nd, 3rd and 4th week. Blood was collected from
aorta abdominalis for biochemical analysis and Periph-
eral Blood Mononuclear Cells (PBMC) isolation.
Fig. 1 The 3D-HPLC chromatogram of JTW. a 3D-HPLC fingerprint of JTW; b HPLC chromatograms of six standard chemicals; c HPLC chromatogram
from ten different batches of JTW to detect the similarity. Standardization of JTW was done using HPLC fingerprinting with chemical standards including
cinnamon acid, jatrorrhizine hydrochloride, coptisine hydrochloride, palmatine hydrochloride, berberine hydrochloride, cinnamaldehyde
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Surgery, sleep recordings and analysis
Another five rats in each group underwent surgery
1 week prior to any PSD subjection or JTW intake, using
standard procedures as bellow [25]. Under pentobarbital
(50 mg/kg, intraperitoneal injection)-induced anesthesia,
two stainless steel screws (2 mm long, 1.2 mm of diam-
eter) attached to insulated wire were implanted in the
skull over the frontal-parietal cortex for electroencepha-
lographic (EEG) recordings. One of the electrodes was
placed approximately 2 mm anterior and 5 mm to the
right of bregma; another was placed approximately
2 mm anterior and 5 mm to the left of bregma. Both of
the electrodes were attached to a miniature connector.
All connectors were cemented in place with dental
acrylic. Right after the surgical implantation, the rats
were injected with Penicillin sodium (80,000 unit dose
for each rat) for 2 days and allowed to recover for 7 days
prior to the initiation of the experiments. At the end of
the 4th week, EEG recordings were collected. For the
purpose of habituation, the animals were connected to
the recording apparatus at least 1 day before the experi-
ments for EEG recordings. The miniature connectors
were connected to a RM-6280C 8-channel physiological
signal recorder (Chengdu Instrument Factory, Chengdu,
China) via the signal input lines. Make sure the animal
can move freely within a wide range. The signals were
amplified and filtered (1 ~ 30 Hz) digitized at a speed of
200 ms/disc, and recorded using Model RM6280C
physiological signal acquisition and processing system.
The system was run for EEG recording continuously for
4 h (10:00–14:00). The EEG waveform files were saved
and the waves ratio tables were exported for further ana-
lysis. The power spectrum densities, integrated and aver-
aged, could be divided into four frequency areas: δ wave
(0.5 ~ 4 Hz), θ wave (4 ~ 8 Hz),αwave (8 ~ 14 Hz), and β
wave (14 ~ 30 Hz). According to rat EEG, each epoch
was assigned to one of the following categories [26]:
wakefulness (can be divided into two types of EEG: θ
wave (4 ~ 8 Hz) when the rats in walking, climbing, ex-
ploring and focus behavior; irregular high-frequency and
low-amplitude EEG activity when the rats licking the
body and standing still), slow-wave sleep stage I (SWS1,
high-amplitude, low-frequency (1 ~ 5 Hz) and spindle
waves (8 ~ 14 Hz) synchronous pattern activity, and
high-amplitude and low-frequency wave ratio less than
50% share in each of the statistical unit (30 s), eyes
closed, usually lying on the animal’s side or curled up
with head down), slow-wave sleep stage II (SWS2, same
as SWS1, but high-amplitude and low-frequency wave
ratio more than 50% share in each of the statistical unit),
REM sleep (low-frequency θ wave, with no significant
difference between the waking state, occasional body
twitches while maintaining a recumbent sleep posture.
Since wakefulness could not directly turn to the REM
sleep state, there was always the presence of SWS sleep
before the REM sleep, and REM sleep could be directly
convert into wakefulness or SWS sleep. REM sleeping
time generally sustained not more than 3 min). Each in-
dividual sleeping phase lasted at least 20 s, and each
analysis unit was 30 s. The total sleep time, total time of
slow wave sleep (SWStotal), SWS1 and SWS2, and total
time of REM sleep were calculated to analyze the differ-
ences among the four groups.
Determination of plasma hs-CRP, TNF-α and IL-6 levels
Plasma high-sensitivity C reactive protein (hs-CRP),
tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-
6) levels were determined using the ELISA kits (Boster
Bio-engineering Co., Ltd., Wuhan, China), according to
the manufacturer’s protocol.
Measurement of body weight increase rate, FPG, FINS
levels and HOMA-IR
The body weight increase rate (%) was calculated by the
net weight increase (g) each week divided by the previ-
ous weight (g). Fasting plasma glucose (FPG) was mea-
sured by the glucose oxidase method using a
commercially available kit (Mingdian Bio-engineering
Co., Ltd., Shanghai, China) and fasting insulin (FINS)
level was determined by ELISA method (Boatman Bio-
tech Co., Ltd., Shanghai, China). The homeostasis model
assessment index of IR (HOMA-IR) was calculated using
the formula of FPG (mmol/L) × FINS (μIU/mL)/22.5.
Assessment of clock gene Cry and inflammation gene
NF-κB expression in PBMC
The PBMC in different groups was isolated by using a
Ficoll density gradient separation kit (Haoyang Biological
Manufacture Co., Ltd., Tianjin, China) as previously de-
scribed [27]. The resulting cells were re-suspended in
1 ml Trizol (Ambion Inc., Austin, TX, USA) and stored
at −80 °C. Total RNA was extracted according to the
manufacturer’s instructions. The purity and concentra-
tion of the extracted RNA were measured by a Nucleic
Acid/Protein Analyzer (Thermo, Rockford, USA). Then
1 μg of total RNA was reverse-transcribed using a Prime
Script RT reagent Kit in a total reaction volume of 20 μl.
cDNA was synthesized in a Mastercycler gradient PCR
apparatus (Eppendorf Company, Hamburg, Germany).
Then 2.0 μl of this cDNA was amplified in a 20 μl PCR
reaction mixture containing 6.8 μl ddH2O, 0.4 μl for-
ward primer, 0.4 μl reverse primer, 0.4 μl ROX Reference
Dye (50×) and 10.0 μl SYBR premix EX Taq™ (TaKaRa
Company, Dalian, China) with an Applied Biosystems
StepOne Real-Time PCR System (StepOne, Foster City,
USA). The reaction included 40 cycles of the following 3
stages: stage1, 95 °C for 30 s; stage2, 95 °C for 5 s,; stage
3, 60 °C for 30 s. The primer sequences were shown in
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Table 1. The method of 2-ΔΔCTwas used to calculate the
relative expression level of each group.
Statistical analysis
Data were presented as mean ± standard deviation (SD)
and analyzed using SPSS 19.0 software. One-way analysis
of variance (ANOVA) was used to determine the statis-
tical significance, followed by a LSD post hoc test (for
equal variances) or a Dunnett’s T3 post hoc test (for not
assumed equal variances). p < 0.05 was considered statis-
tically significant.
Results
3D-HPLC profile of JTW
3D-HPLC chromatogram of JTW was shown in Fig. 1a.
Six of the constituents in JTW were identified by com-
paring the retention time and peak height with reference
standard (Fig.1b). The main constituents of JTW were as
follows: cinnamon acid, jatrorrhizine hydrochloride, cop-
tisine hydrochloride, palmatine chloride, berberine
hydrochloride and cinnamaldehyde. HPLC chromato-
gram of JTW from ten batches was shown in Fig. 1c and
the similarity coefficients were no less than 0.99
The effect of JTW on sleep parameters in sleep-
deprivated OR rats
As shown in Table 2, during the 4 h EEG recording con-
dition, total sleep time and total SWS time were signifi-
cantly reduced in OR rats with PSD (p < 0.01). Time
spent in SWS1 and SWS2 were also decreased (p < 0.01).
However, JTW1 and JTW2 treatment increased total
sleep time, SWStotal time, especially SWS1 time in OR
rats with PSD (p < 0.01). And JTW1 and JTW2 slightly
increased the SWS2 time compared with the model
group. As for REM time, there was no significant differ-
ence among these four groups (data not shown). The re-
sult suggests that JTW has a beneficial effect on
extending the total sleeping time, especially SWS1 time
in OR rats with PSD, changing the structure to a better
state more suitable for sleeping.
The effect of JTW on plasma inflammatory biomarkers in
sleep-deprivated OR rats
As shown in Fig. 2a-c, plasma hs-CRP, TNF-α and IL-6
levels were significantly elevated (p < 0.05, p < 0.01) each
week in OR rats with PSD, indicating systemic inflam-
mation after sleep curtailment. Treatment with JTW1
and JTW2 exhibited a decrease in the level of plasma in-
flammatory biomarkers compared with the model group.
This reduction trend was observed throughout the
deprivation period and reached statistical significance at
the end of the fourth week (p < 0.05, p < 0.01). In
addition, plasma TNF-α level was markedly lower (p <
0.05) in JTW2-treated rats at the end of the third week
compared to that in model rats (Fig. 2b). IL-6 level was
also lower at the end of the second week (p < 0.01) in
JTW2-treated rats (Fig. 2c). The result suggests that
JTW has a beneficial effect on alleviating sleep-loss
related inflammation in OR rats.
The effect of JTW on metabolic parameters in sleep-
deprivated OR rats
The body weight increase rate each week was markedly
higher (p < 0.01) in model rats than that in control rats
(Fig. 3a). It indicates that partially sleep-deprivated OR
rats gained more weight during the whole sleep
deprivation period. Similar changes were also found in
the levels of FINS and HOMA-IR (Fig. 3c-d). However,
partial sleep deprivation caused a slight elevation in FPG
in model rats and FPG level was significantly higher (p <
0.05) than that in control rats at the end of the fourth
week (Fig. 3b). Compared with model rats, JTW1 and
JTW2-treated rats showed the decreases in body weight
increase rate (p < 0.05), and JTW2 administration signifi-
cantly decreased FPG, FINS and HOMA-IR (p < 0.05).
The differences reached statistical significance at the end
of the third or the fourth week (p < 0.05) (Fig. 3a-d). The
result suggests that chronic sleep deprivation is often as-
sociated with insulin resistance which can be attenuated
after the intervention of JTW2.
Table 1 Real-time PCR primer sequences for Cry1, Cry2 and
NF-κB





















Slow wave sleep (s)
SWStotal SWS1 SWS2
Control 14,100 ± 198 14,076 ± 231 7650 ± 1672 6426 ± 1640
Model 6492 ± 486## 6471 ± 485## 4467 ± 387## 2004 ± 730##
JTW1 10,450 ± 308** 10,380 ± 314** 7600 ± 273** 2780 ± 152
JTW2 12,513 ± 385** 12,486 ± 434** 9534 ± 402** 2952 ± 276
Data are expressed as mean ± SD (s, n = 5). SWStotal: total slow wave sleep
time; SWS1: slow-wave sleep stage I time; SWS2: slow-wave sleep stage II time.
##p < 0.01 vs. control group, **p < 0.01 vs. model group
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The effect of JTW on Cry1mRNA,Cry2mRNA and NF-
κBmRNA expressions in PBMC of sleep-deprivated OR rats
As previously reported, clock protein Cry and inflamma-
tion mediator NF-κB both regulate the expression of
proinflammatory cytokines [28, 29]. The activation of
NF-κB signaling pathway is also involved in the develop-
ment of insulin resistance [30]. Thus we measured
Cry1mRNA, Cry2mRNA and NF-κBmRNA expres-
sions in PBMC of sleep-deprivated OR rats. At the
end of the fourth week, the Cry1mRNA and
Cry2mRNA expressions were markedly decreased
while the NF-κBmRNA expression was increased in
PBMC of model rats compared with those in control
rats (p < 0.01) (Fig. 4a-c). However, the administration
of JTW1 and JTW2 reversed the above changes
followed by PSD (p < 0.01) (Fig. 4a-c). The results
suggest that the beneficial effects of JTW on inflam-
mation and insulin resistance may be associated with
Fig. 2 The effect of JTW on plasma inflammatory biomarkers in sleep-deprivated OR rats. JTW supplementation decreased the level of plasma
inflammatory biomarkers in OR rats with PSD (a hs-CRP; b TNF-α; c IL-6). #p < 0.05, ##p < 0.01, significantly different from control. *p < 0.05,
**p < 0.01, significantly different from model group. Each point represents the mean of 5 rats
Fig. 3 The effect of JTW on metabolic parameters in sleep-deprivated OR rats. JTW treatment decreased the level of metabolic parameters in
OR rats with PSD (a Body weight increase rate; b FPG; c FINS; d HOMA-IR). #p < 0.05, ##p < 0.01, significantly different from control. *p < 0.05,
significantly different from model group. Each point represents the mean of 5 rats
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the modulation of circadian clock and inflammation
genes expressions in PBMC.
Discussion
Traditional Chinese medicine has been used to treat in-
somnia for a long time during Chinese history. However,
the underlying mechanism remains unclear. In the
present study, we explored the effects and mechanism of
JTW on sleep in OR rats with chronic PSD. The result
showed that JTW could significantly improve sleep qual-
ity in OR rats after sleep curtailment. JTW could also
attenuate sleep loss-related inflammation and metabolic
disorders. These effects may be associated with the
modulation of circadian clock and inflammation genes
expressions. All the experimental data indicate that JTW
has an obvious hypnotic effect and possesses anti-
inflammation effect and insulin sensitizing activity.
Human beings keep wakefulness during the day and
sleep at night. This sleep/wake cycle is under the control
of circadian clock. Circadian clock is the body’s bio-
logical rhythm in keeping with the 24-h day-night cycle
or light-dark transitions. In mammals, the circadian
timekeeping system is composed of a central clock in
the brain’s suprachiasmatic nuclei (SCN) and peripheral
clocks in nearly every body cell [31]. At the core of this
clock network is a set of interacting transcriptional acti-
vators (CLOCK and BMAL1) and repressors (Period and
Cryptochrome) [32]. Recent study has found that clock
protein Cryptochrome (Cry1 and Cry2) regulates the ex-
pression of proinflammatory cytokines. The absence of
Cry1 and Cry2 might elevate intracellular cAMP level
and activate protein kinase A (PKA), leading to NF-κB
activation through phosphorylation of p65 at S276 [28].
NF-κB is one of the most important regulators of vari-
ous proinflammatory genes expression. Synthesis of in-
flammatory cytokines, such as TNF-α, IL-1β and IL-6, is
all mediated by NF-κB. The activated NF-κB enters the
nucleus where it binds to target DNA elements and en-
hances the transcription of inflammatory genes [29].
This may partially explain the link between circadian
rhythm disruption and increased susceptibility to
chronic inflammatory diseases.
In the present study, environmental noise seriously
disturbed the sleep architecture in OR rat, manifesting
as the reduction of total sleep time and total SWS time.
SWS plays an important role in glucose regulation and
the suppression of SWS may result in decreased insulin
sensitivity, leading to impaired glucose tolerance and in-
creased diabetes risk [33]. In addition, environmental
noise caused a marked decrease in the expressions of
clock gene Cry1mRNA and Cry2mRNA and the increase
in the expression of NF-κB mRNA in PBMC, indicating
the disruption of the circadian rhythm and the activation
of inflammation. As a result, plasma TNF-α, IL-1β and
IL-6 levels were increased since these inflammatory
cytokines are all secreted from PBMC [34]. However,
JTW treatment increased total sleep time and total SWS
time in OR rats with PSD while decreased plasma in-
flammatory cytokines levels. It suggested that JTW has
the beneficial effects on sleep loss and the sleep-loss
Fig. 4 Effects of JTW on Cry1, Cry2, NF-κB mRNA expressions in PBMC of sleep-deprivated OR rats. JTW treatment increased the level of Cry1mRNA,
Cry2mRNA expressions and decreased the level of NF-κBmRNA expression in PBMC of sleep-deprivated OR rats (a Cry1mRNA; b Cry2mRNA;
c NF-κBmRNA). ##p< 0.01, significantly different from control. **p< 0.01, significantly different from model group. Each point represents the mean of 4 rats
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related inflammation. These effects may be associated
with the regulation of the expression of Cry1mRNA,
Cry2mRNA and NF-κB mRNA.
In addition, chronic PSD by environmental noise led
to a significant weight gain and insulin resistance in OR
rats, which is consistent with previous report [23]. In
Mavanji’s study, the model rats gained more weight than
non-deprivated controls after 8 h PSD daily for 9 days.
They also found that poor-quality sleep during rest
period leads to enhanced food intake and this may con-
tribute to the weight gain in OR rats. Since we did not
record the total and daily food intake in the rats, it is
lack of evidence to support this idea. This is also one
limitation of our study. However, compared with Mavan-
ji’s method, we administered a milder sleep deprivation
using a less stressful method (4 h PSD daily for 28 days)
to the rats. And we measured the changes of systemic
inflammatory condition and metabolic markers which
were absent in Mavanji’s study. The result showed
that sleep curtailment led to a remarkable increase in
body weight, FPG, FINS and HOMA-IR. It may attri-
bute to sleep loss-associated inflammation since there
is evidence to suggest that chronic low-grade inflam-
mation is a link between obesity and metabolic syn-
drome. Many studies have proved that inflammatory
cytokines such as TNF-α and IL-6 could decrease in-
sulin sensitivity by negatively affecting the insulin sig-
naling pathway [35, 36]. However, JTW treatment
reversed weight gain and improved insulin sensitivity
in OR rats with PSD which may be related to its
anti-inflammatory effect.
Conclusions
In conclusion, our study successfully established a rat
model of sleep loss, inflammation and insulin resistance.
We also demonstrated that JTW improves sleep, inflam-
mation and insulin sensitivity. The therapeutic effect of
JTW may mainly be derived from its modulation of cir-
cadian clock and inflammation genes expressions in
PBMC.
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